Document is current
Any future updates will be listed below
-
Authors
Gaßner, Heiko https://orcid.org/0000-0003-2037-9460
Trutt, Elmar
Seifferth, Sarah
Friedrich, Jana
Zucker, Diana
Salhani, Ziad
Adler, Werner
Winkler, Jürgen
Jost, Wolfgang H.
-
Funding
Funding for this research was provided by:
Dietmar Hopp Stiftung
Innovative Medicines Initiative 2 Joint Undertaking (820820)
Fraunhofer-Gesellschaft (Attract 044-602140, 044-602150)
Deutsche Forschungsgemeinschaft (438496663 (Mobility_APP))
Forschungsstiftung Medizin Universitätsklinikum Erlangen
Deutsche Forschungsgemeinschaft (SFB 1483—Project-ID 442419336, EmpkinS.)
Friedrich-Alexander-Universität Erlangen-Nürnberg
- License Information
-
More Information
Article History
Received: 8 March 2022
Accepted: 9 May 2022
First Online: 13 June 2022
Declarations
:
: ET, SS, JF, DZ, ZS, WA and WHJ declare no conflict of interest. HG and JW received an institutional research grant by the Federal Ministry of Education and Research, Germany (project: treatHSP, grant number 01GM1905) outside of the submitted work. JW reports personal fees outside of the submitted work from Zambon GmbH, BIAL Deutschland GmbH, and UCB Pharma GmbH.
: This study has been approved by the local ethics committee (reference number: F-2019–052, Landesärztekammer Baden-Württemberg, Stuttgart, Germany) and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
